A comparison between experimental and authentic blood/serum ratios of 3,4-methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine

Journal of Analytical Toxicology

Volumn 33, Issue 5, 2009, Pages 283-286

  Boy, Regine Garcia ^a   Henseler, Joerg ^b   Ramaekers, Johannes G ^c   Mattern, Rainer ^a   Skopp, Gisela ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ANALYSIS OF COVARIANCE; ARTICLE; BLOOD; BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; EXPERIMENTAL STUDY; FIELD STUDY; HEMATOCRIT; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; NORMAL HUMAN; REGRESSION ANALYSIS; SERUM; TANDEM MASS SPECTROMETRY;

EID: 68949098140     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/33.5.283     Document Type: Article

References (21)

1. United Nations Office on Drugs and Crime. World Drug Report. United Nations, New York, NY, 2008.
2. P.J. Hooft and H.P. van de Voorde. Reckless behaviour related to the use of 3,4-methylenedioxymethamphetamine (ecstasy): apropos of a fatal accident during car-surfing. Int. J. Legal Med. 106: 328-329 (1994).
3. H.H. Maurer, J. Bickeboeller-Friedrich, T. Kraemer, and F.T. Peters. Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy'). Toxicol. Lett. 112-113: 133-142 (2000).
4. D. Wu, S.V. Otton, T. Inaba,W. Kalow, and E.M. Sellers. Interactions of amphetamine analogs with human liver CYP2D6. Biochem. Pharmacol. 53: 1605-1612 (1997).
5. H.J. Helmlin, K. Bracher, D. Bourquin, D. Vonlanthen, and R. Brenneisen. Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS. J. Anal. Toxicol. 20: 432-440 (1996).
6. V.W. Hanson, M.H. Buonarati, R.C. Baselt, N.A. Wade, C. Yep, A.A. Biasotti, V.C. Reeve, A.S. Wong, and M.W. Orbanowsky. Comparison of 3H- and 125I-radioimmunoassay and gas chromatography/ mass spectrometry for the determination of delta 9-tetrahydrocannabinol and cannabinoids in blood and serum. J. Anal. Toxicol. 7: 96-102 (1983).
7. M. Widman, S. Agurell, M. Ehrnebo, and G. Jones. Binding of (+)- and (-)-delta-1-tetrahydrocannabinols and (-)-7-hydroxydelta- 1-tetrahydrocannabinol to blood cells and plasma proteins in man. J. Pharm. Pharmacol. 26: 914-916 (1974).
8. K.P. Maguire, G.D. Burrows, T.R. Norman, and B.A. Scoggins. Blood/plasma distribution ratios of psychotropic drugs. Clin. Chem. 26: 1624-1625 (1980).
9. D.J. Crouch, D.E. Rollins, D.V. Canfield, D.M. Andrenyak, and J.E. Schulties. Quantitation of alprazolam and α-hydroxyalprazolam in human plasma using liquid chromatography electrospray ionization MS-MS. J. Anal. Toxicol. 23: 479-485 (1999).
10. H.J. Shull, G.R. Wilkinson, R. Johnson, and S. Schenker. Normal disposition of oxazepam in acute viral hepatitis and cirrhosis. Ann. Intern. Med. 84: 420-425 (1976).
11. A.W. Jones and H. Larsson. Distribution of diazepam and nordiazepam between plasma and whole blood and the influence of hematocrit. Ther. Drug Monit. 26: 380-385 (2004).
12. C.W. Hand, R.A. Moore, and J.W. Sear. Comparison of whole blood and plasma morphine. J. Anal. Toxicol. 12: 234-235 (1988).
13. G. Skopp, L. Potsch, B. Ganssmann, R. Aderjan, and R. Mattern. A preliminary study on the distribution of morphine and its glucuronides in the subcompartments of blood. J. Anal. Toxicol. 22: 261-264 (1998).
14. W.D. Darwin and E.J. Cone. Codeine concentrations in plasma versus aged whole blood. Proceedings TIAFT, Tampa, FL, 1994.
15. G. Skopp, K. Klinder, L. Potsch, G. Zimmer, R. Lutz, R. Aderjan, and R. Mattern. Postmortem distribution of dihydrocodeine and metabolites in a fatal case of dihydrocodeine intoxication. Forensic Sci. Int. 95: 99-107 (1998).
16. 9-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people. Forensic Sci. Int. 123: 159-164 (2001).
17. S. Eksborg, H. Ehrsson, and B. Ekqvist. Protein binding of anthraquinone glycosides, with special reference to adriamycin. Cancer Chemother. Pharmacol. 10: 7-10 (1982).
18. E.A. De Letter, P. De Paepe, K.M. Clauwaert, F.M. Belpaire, W.E. Lambert, J.F. Van Bocxlaer, and M.H. Piette. Is vitreous humour useful for the interpretation of 3,4-methylenedioxymethamphetamine (MDMA) blood levels? Experimental approach with rabbits. Int. J. Legal Med. 114: 29-35 (2000).
19. E.R. Garrett, K. Seyda, and P. Marroum. High performance liquid chromatographic assays of the illicit designer drug "Ecstasy", a modified amphetamine, with applications to stability, partitioning and plasma protein binding. Acta Pharm. Nord. 3: 9-14 (1991).
20. Geigy Scientific Tables, C. Lentner, Ed. Ciba Geigy, Basle, Switzerland, 1997.
21. A.W. Jones, A. Holmgren, and F.C. Kugelberg. Driving under the influence of central stimulant amines: age and gender differences in concentrations of amphetamine, methamphetamine, and ecstasy in blood. J. Stud. Alcohol Drugs 69: 202-208 (2008).